Platinum versus immunotherapy for unresectable esophageal cancer: A protocol for systematic review and meta analysis

BACKGROUND: Esophageal cancer is one of the most common malignant tumors, with early metastasis, highly malignant characteristics. Morbidity ranks 7th among all malignant tumors, and mortality ranks 6th. Esophageal adjuvant therapy can significantly improve overall survival in unresectable esophagea...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Jiekun, Tong, Zhangwei, Zhang, Yannan, Chen, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748184/
https://www.ncbi.nlm.nih.gov/pubmed/33371077
http://dx.doi.org/10.1097/MD.0000000000023537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748184/
https://www.ncbi.nlm.nih.gov/pubmed/33371077
http://dx.doi.org/10.1097/MD.0000000000023537

Ejemplares similares